117 related articles for article (PubMed ID: 10477366)
21. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
[TBL] [Abstract][Full Text] [Related]
22. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
23. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy.
Graesslin O; Chantot-Bastaraud S; Lorenzato M; Birembaut P; Quéreux C; Daraï E
Ann Surg Oncol; 2008 Feb; 15(2):484-92. PubMed ID: 18071824
[TBL] [Abstract][Full Text] [Related]
25. Correlation between DNA content and p53 deletion in colorectal cancer.
Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
Edström S; Cvetkovska E; Westin T; Young C
Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
28. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
29. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
[TBL] [Abstract][Full Text] [Related]
30. [The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer].
Kawamura K; Ikeda R; Suzuki K
Hinyokika Kiyo; 2000 Jun; 46(6):377-83. PubMed ID: 10934605
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
32. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
33. [Gene p53 mutations and overexpression of p53 protein in tumors of the Vater's ampulla].
Terris B; Muzeau F; Sauvanet A; Belghiti J; Fléjou JF
Gastroenterol Clin Biol; 1998 May; 22(5):495-9. PubMed ID: 9762287
[TBL] [Abstract][Full Text] [Related]
34. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
[TBL] [Abstract][Full Text] [Related]
35. Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features.
Ghavam-Nasiri MR; Rezaei E; Ghafarzadegan K; Seilanian-Toosi M; Malekifard H
Arch Iran Med; 2007 Jan; 10(1):38-42. PubMed ID: 17198452
[TBL] [Abstract][Full Text] [Related]
36. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
[TBL] [Abstract][Full Text] [Related]
37. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
[TBL] [Abstract][Full Text] [Related]
38. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
39. [Nuclear DNA content in tumors of the colon and rectum. Relationship between ploidy and site of the neoplasm].
Larghero GC; Ottonello M; Testa T; Scarpettini S; Abbondati A; Capponi G
Minerva Chir; 1990 Mar; 45(5):247-50. PubMed ID: 2377295
[TBL] [Abstract][Full Text] [Related]
40. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]